$71.43 -3.24 (%) Astrazeneca Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Sep. 23, 2014 | 02:06 PM

Partner Headlines

  1. Inversion Crackdown Leaves Several Deals In Limbo

    Benzinga | Sep. 23, 2014 | 12:41PM EST
  2. Midday Losers From September 23 - Alco Stores Inc, CarMax, Inc And More

    Benzinga | Sep. 23, 2014 | 12:37PM EST
  3. Markets Mixed; Carnival Profit Tops Street View

    Benzinga | Sep. 23, 2014 | 11:20AM EST
  4. Drug giants target Alzheimer's

    IBD | Sep. 16, 2014 | 18:49PM EST
  5. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD | Sep. 5, 2014 | 17:06PM EST
  6. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD | Sep. 4, 2014 | 16:33PM EST
  7. Teva Announces UK High Court Gives Positive Judgment In The Company's Patent Case Against AstraZeneca

    Benzinga | Sep. 3, 2014 | 05:10AM EST
  8. SunTrust Sees Further Pfizer Inc. Bid For AstraZeneca PLC 'Highly Likely'

    Benzinga | Sep. 2, 2014 | 15:35PM EST
  9. AstraZeneca

    IBD | Aug. 29, 2014 | 18:54PM EST
  10. Deutsche Bank Says Pfizer Has A Strong Financial Position And Attractive Pipeline

    Benzinga | Aug. 27, 2014 | 11:25AM EST
  11. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD | Aug. 27, 2014 | 08:02AM EST
  12. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD | Aug. 26, 2014 | 12:07PM EST
  13. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga | Aug. 25, 2014 | 16:03PM EST
  14. Illumina lines up key partners

    IBD | Aug. 21, 2014 | 18:41PM EST
  15. Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole

    Benzinga | Aug. 21, 2014 | 17:16PM EST
  16. Illumina Forms Partnerships With Big Pharma Firms

    IBD | Aug. 21, 2014 | 12:03PM EST
  17. Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

    Benzinga | Aug. 21, 2014 | 11:39AM EST
  18. Stocks Open Higher, Turn Mixed; Illumina Rises, Autohome Slips

    IBD | Aug. 21, 2014 | 10:35AM EST
  19. Treasury Develolping Options to Curb Inversions

    FoxBusiness | Aug. 18, 2014 | 13:34PM EST
  20. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD | Aug. 6, 2014 | 10:15AM EST
  21. Drugmaker AstraZeneca Returns To Growth

    IBD | Aug. 5, 2014 | 17:22PM EST
  22. Walgreen Names New CFO Ahead of Possible Inversion

    IBD | Aug. 4, 2014 | 12:29PM EST
  23. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus | Jul. 31, 2014 | 11:18AM EST
  24. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga | Jul. 30, 2014 | 16:43PM EST
  25. Citigroup Comments On Potential Pfizer/AstraZeneca Acquisition

    Benzinga | Jul. 29, 2014 | 11:49AM EST
  26. Merck, Pfizer Beat Q2 Earnings Estimates

    IBD | Jul. 29, 2014 | 11:23AM EST
  27. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD | Jul. 28, 2014 | 13:02PM EST
  28. Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls

    IBD | Jul. 28, 2014 | 11:14AM EST
  29. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga | Jul. 26, 2014 | 13:58PM EST
  30. FT: 25 More Firms May Seek Tax Breaks Overseas

    FoxBusiness | Jul. 22, 2014 | 16:59PM EST
  31. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness | Jul. 18, 2014 | 13:23PM EST
  32. I Believe AstraZeneca Is Fairly Valued

    GuruFocus | Jul. 16, 2014 | 11:35AM EST
  33. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts | Jul. 11, 2014 | 19:34PM EST
  34. British Blue Chips Beckon

    Benzinga | Jul. 11, 2014 | 09:20AM EST
  35. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield

    Benzinga | Jul. 11, 2014 | 04:14AM EST
  36. In Pursuit of Shire, AbbVie Eyes Lower Taxes in UK

    FoxBusiness | Jul. 8, 2014 | 13:20PM EST
  37. Dow Trades Above 17,000 While S&P 500 Inches Closer To 2,000

    Benzinga | Jul. 3, 2014 | 13:20PM EST
  38. Bind Therapeutics Down After Losing Amgen Partnership

    IBD | Jul. 3, 2014 | 11:31AM EST
  39. S&P: Cut Corporate Taxes to Create 10M New Jobs

    FoxBusiness | Jun. 26, 2014 | 16:38PM EST
  40. Rumor Of Massive Monsanto-Syngenta Deal Gets Agriculture Sector Moving

    Benzinga | Jun. 23, 2014 | 14:06PM EST
  41. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness | Jun. 20, 2014 | 12:31PM EST
  42. Global M&A Up 73% To $1.6 Trillion; Health, Media Top

    IBD | Jun. 16, 2014 | 18:59PM EST
  43. Medtronic to Buy Covidien for $42.0 Billion

    FoxBusiness | Jun. 16, 2014 | 09:24AM EST
  44. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD | Jun. 13, 2014 | 17:29PM EST
  45. Morning Market Movers

    Benzinga | Jun. 10, 2014 | 09:39AM EST
  46. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy

    Benzinga | Jun. 4, 2014 | 10:32AM EST
  47. ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects

    Benzinga | Jun. 4, 2014 | 10:11AM EST
  48. M&A Activity Fearless Against Rate Hikes

    FoxBusiness | Jun. 4, 2014 | 08:49AM EST
  49. AstraZeneca sees deal hurdles

    IBD | May. 14, 2014 | 18:40PM EST
  50. A Bitter Pill

    FoxBusiness | May. 14, 2014 | 13:44PM EST
Trading Center